Form Filed By SHAW SETH M
Fri, Oct 6, 2017
Go to original document
TAURIGA SCIENCES, INC. (TAUG)
Healthcare
Drug Manufacturers—Specialty & Generic
Insights
Coming soon
Non Derivative Transactions
2017-10-06
Common Stock, par value $0.00001
Purchase
P
Type
Acquired 110,000,000 shares @ $0.00 per share
271,390,016 shares
Direct
Footnotes
1. The Reporting Person purchased these shares for an aggregate purchase price of $137,500, or $0.00125 per share. All such shares shall be "restricted securities" as such term is defined by the Securities Act of 1933, as amended.